Picture of Kissei Pharmaceutical logo

4547 — Kissei Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Table: Kissei Pharm -2016/17 group results

May 9 (Reuters)-  
          Kissei Pharmaceutical Co Ltd  
          CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                 Year ended      Year ended       Year to       NEXT    
              Mar 31, 2017    Mar 31, 2016   Mar 31, 2018     YEAR      
                 LATEST         YEAR-AGO        COMPANY      COMPANY    
                 RESULTS         RESULTS       FORECAST    H1 FORECAST  
  Sales           71.71           71.29          73.20        35.50     
               (+0.6 pct)      (+1.7 pct)     (+2.1 pct)    (-0.9 pct)  
  Operating        8.49           10.27           9.00         3.70     
               (-17.4 pct)     (+23.3 pct)    (+6.0 pct)   (-17.3 pct)  
  Recurring        9.64           11.35          10.00         4.20     
               (-15.1 pct)     (+7.3 pct)     (+3.8 pct)   (-13.6 pct)  
  Net 
  Net              7.73            8.17           7.80         3.15     
               (-5.4 pct)      (+14.0 pct)    (+1.0 pct)   (-19.0 pct)  
  EPS          158.74 yen      166.89 yen     161.43 yen    65.19 yen   
  Ann Div       46.00 yen       44.00 yen      48.00 yen                
  -Q2 Div       23.00 yen       22.00 yen      24.00 yen                
  -Q4 Div       23.00 yen       22.00 yen      24.00 yen                
   
  NOTE - Kissei Pharmaceutical Co Ltd. 
  *Second Net profit row denotes profit attributable to owners ofthe parent  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4547.T 
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Kissei Pharmaceutical

See all news